Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 6.7B 1B 874M 821M 750M 1.41B 95.65B 1.41B 9.84B 3.8B 48.84B 3.76B 3.68B 157B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 4.21B 629M 549M 516M 471M 884M 60.1B 884M 6.18B 2.39B 30.68B 2.36B 2.31B 98.95B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day-0.26%
1 week+0.35%
Current month-3.45%
1 month-11.96%
3 months-5.12%
6 months-7.42%
Current year-22.27%
1 week 11.16
Extreme 11.16
11.58
1 month 11.16
Extreme 11.16
13.48
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
15.66
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 58 08/02/2026
Director of Finance/CFO 49 05/12/2021
Corporate Officer/Principal 56 19/03/2025
Director TitleAgeSince
Director/Board Member 66 25/03/2014
Director/Board Member 64 25/09/2017
Director/Board Member 44 25/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
17/07/24 Buy 500 0.0001%
22/01/20 Sell

Director

246,300 0.0462%
01/01/20 Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+0.35%-26.69%-51.07% 1B
+0.45%+1.10%-12.24%-3.06% 13.61B
0.00%+0.38%-31.99%-55.53% 4.85B
+0.33%-1.55%-4.35%-5.10% 4.35B
-0.06%+1.30%-5.35%-30.85% 3.89B
-0.88%-2.64%-2.83%-4.48% 3.44B
-0.28%+1.36%-20.30%+5.09% 3.5B
-0.85%-0.43%-10.75%+3.49% 3.14B
0.00%+1.03%-20.89%-16.22% 2.29B
+0.20%+3.05%-25.76%-20.97% 1.68B
Average -0.13%+1.22%-16.12%-17.87% 4.17B
Weighted average by Cap. +0.02%+1.03%-14.23%-13.49%

Financials

2024 2025
Net sales 3.38B 504M 440M 413M 378M 709M 48.18B 709M 4.96B 1.91B 24.6B 1.89B 1.85B 79.33B 2.32B 346M 302M 284M 259M 487M 33.07B 486M 3.4B 1.31B 16.89B 1.3B 1.27B 54.45B
Net income 492M 73.45M 64.15M 60.24M 55.05M 103M 7.02B 103M 722M 279M 3.58B 276M 270M 11.56B -258M -38.49M -33.62M -31.56M -28.84M -54.12M -3.68B -54.09M -378M -146M -1.88B -145M -141M -6.06B
Net Debt -2.29B -342M -299M -280M -256M -481M -32.67B -480M -3.36B -1.3B -16.68B -1.28B -1.26B -53.78B -2.49B -372M -325M -305M -279M -523M -35.56B -523M -3.66B -1.41B -18.16B -1.4B -1.37B -58.54B
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
22/09/26 CN¥11.48 -0.26% 3,838,814
21/09/26 CN¥11.51 +2.31% 5,907,230
18/09/26 CN¥11.25 +0.27% 3,547,019
17/09/26 CN¥11.22 -0.27% 2,494,499
16/09/26 CN¥11.25 -0.53% 2,874,543

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!